SMAD2 and hepatocellular carcinoma: In addition, it has been shown that FOXP1 can affect the activation of the TGF-β pathway by binding to the transcription factors Smad2 and Smad3, thereby causing CD8+ T cells de-lymphotoxicity in hepatocellular carcinoma tissues.